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INTRODUCTION: A key impediment to repair 
following central nervous system (CNS) injury is 
the formation of a glial scar which inhibits 
neuronal growth beyond implanted tissue 
engineered devices [1]. Astrocytes, which support 
neuronal function in healthy tissue, undergo 
characteristic changes to form this 
physical/chemical barrier at the boundary of 
regeneration, but the precise nature of this response 
is poorly understood. One of the principle 
limitations to research in this field is the lack of an 
effective cell culture model; astrocytes in 
conventional culture support the growth of 
neurones despite expressing features of the reactive 
phenotype. However, astrocytes in 3-dimensional 
(3D) culture can inhibit neuronal growth [2]. The 
aim here is to grow astrocytes in a 3D co-culture 
model in order to mimic the host CNS repair 
environment where they encounter Schwann cells 
and regenerating neurones at the interface of 
implanted conduits [1]. 
METHODS: Primary astrocytes were prepared 
from neonatal rats [3] and seeded within 1 ml 
cylindrical collagen gels formed from type I rat tail 
collagen (1.92 mg/ml). Dorsal root ganglia (DRGs) 
were harvested from adult rats and either (i) 
dissociated using collagenase and injected into the 
centre of the astrocyte gel, or (ii) embedded as 
intact ganglia within the astrocyte gel during 
setting. These co-culture systems were maintained 
for 11 days, then astrocyte, neurone and Schwann 
cell morphologies were examined using 
immunofluorescence (antibodies against GFAP, 
βIII-tubulin and S100 respectively) detected by 
fluorescence and confocal microscopy. 
RESULTS: A halo of GFAP immunofluorescence 
was detected around the DRG positions. 
Astrocytes adjacent to DRGs were larger and 
displayed a more ramified phenotype than those in 
comparator regions of the same gels (fig 1). 
Classification of astrocyte morphology in the 
DRG-adjacent region confirmed that there were 
significantly more ramified cells here than in the 
control areas (fig 2).  
 
Fig. 1: Confocal micrographs showing 
morphology of astrocytes adjacent (left) and 2mm 
distal (right) to embedded DRG. 
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Fig. 2: Assessment of astrocyte 
morphology in adjacent and 
control regions. 
DISCUSSION & CONCLUSIONS: Astrocytes 
in 3D culture exhibited a localised response to the 
presence of co-cultured DRGs. They became larger 
and more ramified than comparator cells in a 
manner reminiscent of the reactive gliosis observed 
at damage sites in vivo [1]. Recapitulation of the 
astrocytic response in this simple model will 
enable triggers and therapeutic interventions to be 
investigated in a highly controlled environment 
providing a useful tool for future studies.  
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